Bronnen:
- Motzer RJ, Tannir NM, McDermott DV et al. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma. The New England Journal of Medicine. 21 Maart 2018,
Bronnen:
nov 2024 | Longoncologie
nov 2024 | Longoncologie
feb 2024 | Longoncologie
dec 2023 | Uro-oncologie
jun 2021 | Chirurgie, Maag-darm-leveroncologie
feb 2021 | Maag-darm-leveroncologie
jun 2022 | Longoncologie
apr 2022 | Borstkanker
mrt 2022